TP53 and cancer: Indeed, analysis of tumor driver and suppressor genes (n = 378) uncovered that TP53 mutated cancers accumulated more 5-FU mutations than TP53 wild type cancers, both in colon and breast (P < 0.05, Wilcoxon rank-sum test, Fig. 2d).